Novel ‘heart-on-a-chip’ technology could measure compound effects on heart tissue function in the hope of ensuring safety and efficiently of new drugs.
Scientists from Stanford University School of Medicine (CA, USA) have developed a novel lab-on-a-chip that has the potential to improve diagnostic capabilities particularly in the developing world.
Scientists demonstrate a lab-on-a-chip technique that may analyze and identify multiple biomolecular targets from blood.
Researchers have developed a paper chip that utilizes ionic antibody probes to diagnose disease – the device could be used at home to test for malaria and other diseases.
Researchers have developed a new all-on-chip method for neutrophil chemotaxis testing, which is able to rapidly test directly from whole blood using a microfluidic approach.
Mass production of microvalve unit may help manufacture simpler and more robust microfluidic devices.
A low-cost and highly sensitive lab-on-a-chip device that integrates fiber optic glucose sensors and that could improve diabetes diagnosis and monitoring is being developed.
New device has the potential to decrease the cost of sophisticated lab tests for several diseases and medical disorders.
Novel microfluidic chip device shows potential for rapidly detecting Ebola virus.
‘Lab-on-a-Disc’ platform, combining microfluidic techniques with fast optical diagnostics, could dramatically cut the time taken to detect bacterial species responsible for urinary tract infections.